Clinical Trial Update: A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a lithium-based medication for improving neurological outcomes after surgical carotid reconstruction has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Artery Diseases
• Carotid Artery Stenosis

Drugs mentioned

• Lithium-based medication (lithium-based compound)

Snippet

Sponsor: Negovsky Reanimatology Research Institute | Conditions: Carotid Artery Diseases, Carotid Artery Stenosis | Phase 3 | Status: TERMINATED